The reported billions-of-rands loss by Blu Label Unlimited is largely the result of accounting changes linked to the listing and restructuring of Cell C, rather than a collapse in its core operations.
Pre-Listing Restructuring and Share Sale
Ahead of Cell C’s stock market listing, Blu Label’s subsidiary, The Prepaid Company, implemented a restructuring process. This included:
Selling down certain shareholdings
Transferring specific assets
Preparing Cell C for new external investors
These transactions were necessary to position Cell C for its listing and capital restructuring.
Change from Subsidiary to Associate
A major trigger for the accounting loss was the change in Cell C’s classification.
Previously, Blu Label effectively controlled Cell C, meaning it was treated as a subsidiary in group financial statements. However, after selling approximately 30% to third-party investors prior to the listing, Blu Label no longer held a controlling stake.
As a result, Cell C was reclassified from a subsidiary to an associate company. This accounting shift significantly impacted how the investment is reported under international financial reporting standards.
IFRS Accounting Impact and Non-Cash Loss
Under IFRS accounting rules, when a company loses control of a subsidiary, it must:
Recalculate the value of its remaining stake
Recognise any gain or loss in the income statement
This applies even if the adjustment is non-cash and based purely on valuation changes.
The large headline loss therefore reflects the difference between:
Blu Label’s book value of its investment in Cell C, and
The fair market value established during the share sale and listing process.
These accounting adjustments are mandatory under IFRS and do not necessarily reflect operational performance or cash flow losses.
Blu Label’s Underlying Business Remains Profitable
Despite the reported accounting loss, Blu Label confirmed that its core operations remain strong.
On a normalised basis, excluding once-off restructuring costs and Cell C listing adjustments, the company would have reported:
Net profit of approximately R389 million
Revenue of around R5 billion
Positive EBITDA and solid headline earnings per share
Management has emphasised that the IFRS loss is an accounting artefact tied to the complex Cell C restructuring and IPO process, and not a reflection of the group’s day-to-day trading performance.
Dividend Resumption Signals Financial Stability
In a significant move, Blu Label declared an interim dividend of 43.56 cents per share — its first dividend in nearly eight years.
This dividend resumption suggests management believes the company’s balance sheet has stabilised following the long and costly Cell C restructuring process.
The group also confirmed that its financial structure is now:
Simplified
De-risked
More transparent for investors
The removal of complex Cell C funding structures has improved earnings clarity and strengthened Blu Label’s overall investment case.
What the Cell C Listing Means for Blu Label Investors
1. Short-Term Accounting Loss, Long-Term Strategic Positioning
The multi-billion rand loss is largely non-cash and accounting-driven. Adjusted earnings show the business remains profitable.
2. Reduced Risk Exposure
The Cell C listing and share sell-down have reduced Blu Label’s direct operational risk and unlocked capital.
3. Improved Investor Confidence
The return of dividend payments and clearer earnings visibility indicate growing management confidence in Blu Label’s long-term growth strategy.
